Erratum to: Reprogramming triggers endogenous L1 and Alu retrotransposition in human induced pluripotent stem cells (Nature Communications, (2016), 7, 1, (10286), 10.1038/ncomms10286);Reprogramming triggers endogenous L1 and Alu retrotransposition in human induced pluripotent stem cells

Nature Communications

Volumn 7, Issue , 2016, Pages

  Klawitter, Sabine ^a,g   Fuchs, Nina V ^a,b   Upton, Kyle R ^c   Muñoz Lopez, Martin ^d   Shukla, Ruchi ^c   Wang, Jichang ^b   Garcia Cañadas, Marta ^d   Lopez Ruiz, Cesar ^d   Gerhardt, Daniel J ^c   Sebe, Attila ^a   Grabundzija, Ivana ^b   Merkert, Sylvia ^e   Gerdes, Patricia ^c   Pulgarin, J Andres ^d   Bock, Anja ^a   Held, Ulrike ^a   Witthuhn, Anett ^e   Haase, Alexandra ^e   Sarkadi, Balázs ^f   Löwer, Johannes ^a   Wolvetang, Ernst J ^c   Martin, Ulrich ^e   Ivics, Zoltán ^a   Izsvák, Zsuzsanna ^b   Garcia Perez, Jose L ^d   Faulkner, Geoffrey J ^c   Schumann, Gerald G ^a   more..

^a PAUL EHRLICH INSTITUT   (Germany)

^b MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^c UNIVERSITY OF QUEENSLAND   (Australia)

^d UNIVERSITY OF GRANADA   (Spain)

^e HANNOVER MEDICAL SCHOOL   (Germany)

^f SEMMELWEIS UNIVERSITY   (Hungary)

^g UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CULTIVATION; GENE EXPRESSION; GENETICS;

ALU SEQUENCE; CELL LINE; EMBRYONIC STEM CELL; GENE DISRUPTION; HUMAN; INTRON; PLURIPOTENT STEM CELL; RETROPOSON; CELL PROLIFERATION; CELL REPROGRAMMING TECHNIQUE; GENETIC EPIGENESIS; GENETICS; INDUCED PLURIPOTENT STEM CELL; LONG INTERSPERSED REPEAT; METABOLISM; NUCLEAR REPROGRAMMING; VARIABLE NUMBER OF TANDEM REPEAT;

CADPS2 PROTEIN, HUMAN; CALCIUM BINDING PROTEIN; RETROPOSON; VESICULAR TRANSPORT PROTEIN;

ALU ELEMENTS; CALCIUM-BINDING PROTEINS; CELL LINE; CELL PROLIFERATION; CELLULAR REPROGRAMMING; CELLULAR REPROGRAMMING TECHNIQUES; EMBRYONIC STEM CELLS; EPIGENESIS, GENETIC; HUMANS; INDUCED PLURIPOTENT STEM CELLS; LONG INTERSPERSED NUCLEOTIDE ELEMENTS; MINISATELLITE REPEATS; RETROELEMENTS; VESICULAR TRANSPORT PROTEINS;

EID: 84953911769     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/s41467-018-07917-0     Document Type: Erratum

References (74)

1. Yamanaka, S. Induced pluripotent stem cells: past, present, and future. Cell Stem Cell 10, 678-684 (2012).
2. Gore, A. et al. Somatic coding mutations in human induced pluripotent stem cells. Nature 471, 63-67 (2011).
3. Hussein, S. M. et al. Copy number variation and selection during reprogramming to pluripotency. Nature 471, 58-62 (2011).
4. Laurent, L. C. et al. Dynamic changes in the copy number of pluripotency and cell proliferation genes in human ESCs and iPSCs during reprogramming and time in culture. Cell Stem Cell 8, 106-118 (2011).
5. Lister, R. et al. Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells. Nature 471, 68-73 (2011).
6. Mayshar, Y. et al. Identification and classification of chromosomal aberrations in human induced pluripotent stem cells. Cell Stem Cell 7, 521-531 (2010).
7. Ben-David, U. & Benvenisty, N. The tumorigenicity of human embryonic and induced pluripotent stem cells. Nat. Rev. Cancer 11, 268-277 (2011).
8. Levin, H. L. & Moran, J. V. Dynamic interactions between transposable elements and their hosts. Nat. Rev. Genet. 12, 615-627 (2011).
9. Beck, C. R. et al. LINE-1 retrotransposition activity in human genomes. Cell 141, 1159-1170 (2010).
10. Mills, R. E., Bennett, E. A., Iskow, R. C. & Devine, S. E. Which transposable elements are active in the human genome? Trends Genet. 23, 183-191 (2007).
11. Brouha, B. et al. Hot L1s account for the bulk of retrotransposition in the human population. Proc. Natl Acad. Sci. USA 100, 5280-5285 (2003).
12. Ewing, A. D. & Kazazian, Jr. H. H. Whole-genome resequencing allows detection of many rare LINE-1 insertion alleles in humans. Genome Res. 21, 985-990 (2011).
13. Garcia-Perez, J. L. et al. LINE-1 retrotransposition in human embryonic stem cells. Hum. Mol. Genet. 16, 1569-1577 (2007).
14. Kano, H. et al. L1 retrotransposition occurs mainly in embryogenesis and creates somatic mosaicism. Genes Dev. 23, 1303-1312 (2009).
15. Han, J. S., Szak, S. T. & Boeke, J. D. Transcriptional disruption by the L1 retrotransposon and implications for mammalian transcriptomes. Nature 429, 268-274 (2004).
16. Hancks, D. C. & Kazazian, Jr. H. H. Active human retrotransposons: variation and disease. Curr. Opin. Genet. Dev. 22, 191-203 (2012).
17. Beck, C. R., Garcia-Perez, J. L., Badge, R. M. & Moran, J. V. LINE-1 elements in structural variation and disease. Annu. Rev. Genomics Hum. Genet. 12, 187-215 (2011).
18. Bourc'his, D. & Bestor, T. H. Meiotic catastrophe and retrotransposon reactivation in male germ cells lacking Dnmt3L. Nature 431, 96-99 (2004).
19. Maherali, N. et al. Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contribution. Cell Stem Cell 1, 55-70 (2007).
20. Wissing, S. et al. Reprogramming somatic cells into iPS cells activates LINE-1 retroelement mobility. Hum. Mol. Genet. 21, 208-218 (2012).
21. Friedli, M. et al. Loss of transcriptional control over endogenous retroelements during reprogramming to pluripotency. Genome Res. 24, 1251-1259 (2014).
22. Wissing, S., Montano, M., Garcia-Perez, J. L., Moran, J. V. & Greene, W. C. Endogenous APOBEC3B restricts LINE-1 retrotransposition in transformed cells and human embryonic stem cells. J. Biol.Chem. 286, 36427-36437 (2011).
23. Cheng, L. et al. Low incidence of DNA sequence variation in human induced pluripotent stem cells generated by nonintegrating plasmid expression. Cell Stem Cell 10, 337-344 (2012).
24. Quinlan, A. R. et al. Genome sequencing of mouse induced pluripotent stem cells reveals retroelement stability and infrequent DNA rearrangement during reprogramming. Cell Stem Cell 9, 366-373 (2011).
25. Briggs, J. A. et al. Integration-free induced pluripotent stem cells model genetic and neural developmental features of down syndrome etiology. Stem Cells 31, 467-478 (2013).
26. Grabundzija, I. et al. Sleeping Beauty transposon-based system for cellular reprogramming and targeted gene insertion in induced pluripotent stem cells. Nucleic Acids Res. 41, 1829-1847 (2013).
27. Haase, A. et al. Generation of induced pluripotent stem cells from human cord blood. Cell Stem Cell 5, 434-441 (2009).
28. Abyzov, A. et al. Somatic copy number mosaicism in human skin revealed by induced pluripotent stem cells. Nature 492, 438-442 (2012).
29. Goodier, J. L., Zhang, L., Vetter, M. R. & Kazazian, Jr. H. H. LINE-1 ORF1 protein localizes in stress granules with other RNA-binding proteins, including components of RNA interference RNA-induced silencing complex. Mol. Cell. Biol. 27, 6469-6483 (2007).
30. Doucet, A. J. et al. Characterization of LINE-1 ribonucleoprotein particles. PLoS Genet. 6, e1001150 (2010).
31. Rodic, N. et al. Long interspersed element-1 protein expression is a hallmark of many human cancers. Am. J. Pathol. 184, 1280-1286 (2014).
32. Moldovan, J. B. & Moran, J. V. The zinc-finger antiviral protein ZAP inhibits LINE and Alu retrotransposition. PLoS Genet. 11, e1005121 (2015).
33. Shukla, R. et al. Endogenous retrotransposition activates oncogenic pathways in hepatocellular carcinoma. Cell 153, 101-111 (2013).
34. Baillie, J. K. et al. Somatic retrotransposition alters the genetic landscape of the human brain. Nature 479, 534-537 (2011).
35. Ewing, A. D. & Kazazian, Jr. H. H. High-throughput sequencing reveals extensive variation in human-specific L1 content in individual human genomes. Genome Res. 20, 1262-1270 (2010).
36. Iskow, R. C. et al. Natural mutagenesis of human genomes by endogenous retrotransposons. Cell 141, 1253-1261 (2010).
37. Wang, J. et al. dbRIP: a highly integrated database of retrotransposon insertion polymorphisms in humans. Hum. Mutat. 27, 323-329 (2006).
38. Mir, A. A., Philippe, C. & Cristofari, G. euL1db: the European database of L1HS retrotransposon insertions in humans. Nucleic Acids Res. 43, D43-D47 (2015).
39. Wang, H. et al. SVA elements: a hominid-specific retroposon family. J. Mol. Biol. 354, 994-1007 (2005).
40. Symer, D. E. et al. Human l1 retrotransposition is associated with genetic instability in vivo. Cell 110, 327-338 (2002).
41. Raiz, J. et al. The non-Autonomous retrotransposon SVA is trans-mobilized by the human LINE-1 protein machinery. Nucleic Acids Res. 40, 1666-1683 (2012).
42. Gilbert, N., Lutz, S., Morrish, T. A. & Moran, J. V. Multiple fates of L1 retrotransposition intermediates in cultured human cells. Mol. Cell. Biol. 25, 7780-7795 (2005).
43. Luan, D. D., Korman, M. H., Jakubczak, J. L. & Eickbush, T. H. Reverse transcription of R2Bm RNA is primed by a nick at the chromosomal target site: a mechanism for non-LTR retrotransposition. Cell 72, 595-605 (1993).
44. Cost, G. J., Feng, Q., Jacquier, A. & Boeke, J. D. Human L1 element target-primed reverse transcription in vitro. EMBO J. 21, 5899-5910 (2002).
45. Jurka, J. Sequence patterns indicate an enzymatic involvement in integration of mammalian retroposons. Proc. Natl Acad. Sci USA 94, 1872-1877 (1997).
46. Morrish, T. A. et al. DNA repair mediated by endonuclease-independent LINE-1 retrotransposition. Nat. Genet. 31, 159-165 (2002).
47. Zingler, N. et al. Analysis of 5' junctions of human LINE-1 and Alu retrotransposons suggests an alternative model for 5'-end attachment requiring microhomology-mediated end-joining. Genome Res. 15, 780-789 (2005).
48. Ostertag, E. M. & Kazazian, Jr. H. H. Twin priming: a proposed mechanism for the creation of inversions in L1 retrotransposition. Genome Res. 11, 2059-2065 (2001).
49. Grimaldi, G., Skowronski, J. & Singer, M. F. Defining the beginning and end of KpnI family segments. EMBO J. 3, 1753-1759 (1984).
50. Lee, E. et al. Landscape of somatic retrotransposition in human cancers. Science 337, 967-971 (2012).
51. Solyom, S. et al. Extensive somatic L1 retrotransposition in colorectal tumors. Genome Res. 22, 2328-2338 (2012).
52. Moran, J. V. et al. High frequency retrotransposition in cultured mammalian cells. Cell 87, 917-927 (1996).
53. Sassaman, D. M. et al. Many human L1 elements are capable of retrotransposition. Nat. Genet. 16, 37-43 (1997).
54. Cost, G. J., Golding, A., Schlissel, M. S. & Boeke, J. D. Target DNA chromatinization modulates nicking by L1 endonuclease. Nucleic Acids Res. 29, 573-577 (2001).
55. Thurman, R. E. et al. The accessible chromatin landscape of the human genome. Nature 489, 75-82 (2012).
56. Kaer, K. & Speek, M. Retroelements in human disease. Gene 518, 231-241 (2013).
57. Guenther, M. G. et al. Chromatin structure and gene expression programs of human embryonic and induced pluripotent stem cells. Cell Stem Cell 7, 249-257 (2010).
58. Nott, A., Meislin, S. H. & Moore, M. J. A quantitative analysis of intron effects on mammalian gene expression. RNA 9, 607-617 (2003).
59. Schmittgen, T. D. et al. Quantitative reverse transcription-polymerase chain reaction to study mRNA decay: comparison of endpoint and real-time methods. Anal. Biochem. 285, 194-204 (2000).
60. Coufal, N. G. et al. L1 retrotransposition in human neural progenitor cells. Nature 460, 1127-1131 (2009).
61. Arokium, H. et al. Deep sequencing reveals low incidence of endogenous LINE-1 retrotransposition in human induced pluripotent stem cells. PLoS ONE 9, e108682 (2014).
62. Upton, K. R. et al. Ubiquitous L1 mosaicism in hippocampal neurons. Cell 161, 228-239 (2015).
63. van den Hurk, J. A. et al. L1 retrotransposition can occur early in human embryonic development. Hum. Mol. Genet. 16, 1587-1592 (2007).
64. Marchetto, M. C. et al. Differential L1 regulation in pluripotent stem cells of humans and apes. Nature 503, 525-529 (2013).
65. Ostertag, E. M. & Kazazian, Jr. H. H. Biology of mammalian L1 retrotransposons. Annu. Rev. Genet. 35, 501-538 (2001).
66. Coufal, N. G. et al. Ataxia telangiectasia mutated (ATM) modulates long interspersed element-1 (L1) retrotransposition in human neural stem cells. Proc. Natl Acad. Sci. USA 108, 20382-20387 (2011).
67. Kapranov, P. et al. RNA maps reveal new RNA classes and a possible function for pervasive transcription. Science 316, 1484-1488 (2007).
68. Becherel, O. J. et al. A new model to study neurodegeneration in ataxia oculomotor apraxia type 2. Hum. Mol. Genet. 24, 5759-5774 (2015).
69. Andrews, P. W., Bronson, D. L., Benham, F., Strickland, S. & Knowles, B. B. A comparative study of eight cell lines derived from human testicular teratocarcinoma. Int. J. Cancer 26, 269-280 (1980).
70. Kimberland, M. L. et al. Full-length human L1 insertions retain the capacity for high frequency retrotransposition in cultured cells. Hum. Mol. Genet. 8, 1557-1560 (1999).
71. Watanabe, N. & Mitchison, T. J. Single-molecule speckle analysis of actin filament turnover in lamellipodia. Science 295, 1083-1086 (2002).
72. Kopera, H. C., Moldovan, J. B., Morrish, T. A., Garcia-Perez, J. L. & Moran, J. V. Similarities between long interspersed element-1 (LINE-1) reverse transcriptase and telomerase. Proc. Natl Acad. Sci. USA 108, 20345-20350 (2011).
73. Richards, M., Fong, C. Y., Chan, W. K., Wong, P. C. & Bongso, A. Human feeders support prolonged undifferentiated growth of human inner cell masses and embryonic stem cells. Nat. Biotechnol. 20, 933-936 (2002).
74. Thomson, J. A. et al. Embryonic stem cell lines derived from human blastocysts. Science 282, 1145-1147 (1998).